pharma manufacturing

India Cracks Down on GLP-1 Weight Loss Drug Misuse A professional image showing various GLP-1 weight loss drugs, a syringe, and the DCGI logo with India's map in the background.

India Cracks Down on GLP-1 Weight Loss Drug Misuse

sivam March 24, 2026

India's DCGI intensifies crackdown on illegal sales & misleading ads of GLP-1 weight loss drugs. Aiming to...

India Tightens GLP-1 Drug Control Amid Misuse A team of Indian pharmacists in blue coats inspecting shelves of medicines in a modern pharmacy.

India Tightens GLP-1 Drug Control Amid Misuse

sivam March 24, 2026

India's drug regulator increases scrutiny on GLP-1 drugs to prevent misuse and illegal sales, ensuring patient safety...

Affordable Ozempic & Wegovy Generics Hit Indian Market A professional shot of various medicine boxes, some labeled "Ozempic," on a wooden table in a pharmaceutical factory.

A professional shot of various medicine boxes, some labeled "Ozempic," on a wooden table in a pharmaceutical factory.

Affordable Ozempic & Wegovy Generics Hit Indian Market

sivam March 23, 2026

Indian drugmakers launch affordable generic versions of Ozempic & Wegovy, slashing costs by 70%. Increased access to...

Lilly Exec: India a Prime Investment Hub for Pharma R&D A man in a suit gesturing towards a futuristic cityscape with DNA helix and data visualizations, representing pharma investment.

A man in a suit gesturing towards a futuristic cityscape with DNA helix and data visualizations, representing pharma investment.

Lilly Exec: India a Prime Investment Hub for Pharma R&D

sivam March 21, 2026

Lilly International President Patrick Johnson sees India as an attractive investment hub, citing faster clinical trial approvals...

Sun Pharma Launches Affordable Semaglutide in India Pharmaceutical products, including boxes and blister packs of "Noveltreat" and "Sematrinity" on a wooden table.

Pharmaceutical products, including boxes and blister packs of "Noveltreat" and "Sematrinity" on a wooden table.

Sun Pharma Launches Affordable Semaglutide in India

sivam March 21, 2026

Sun Pharma introduces Noveltreat & Sematrinity semaglutide in India, offering affordable alternatives for diabetes & weight management....

Indian Drugmakers Battle for Obesity Market Share Pharmaceutical workers in cleanroom attire oversee packaging on a conveyor belt in a modern Indian factory.

Pharmaceutical workers in cleanroom attire oversee packaging on a conveyor belt in a modern Indian factory.

Indian Drugmakers Battle for Obesity Market Share

sivam March 21, 2026

Indian drugmakers compete for obesity market share as generic weight-loss drugs drive prices down, increasing access but...

Alkem Labs Launches Semaglutide in India for Weight Loss Semaglutide injection pens and packaged boxes are arranged on a white surface within a clean, blurred pharmaceutical lab.

Semaglutide injection pens and packaged boxes are arranged on a white surface within a clean, blurred pharmaceutical lab.

Alkem Labs Launches Semaglutide in India for Weight Loss

sivam March 21, 2026

Alkem Labs enters India's weight-loss market with Semaglutide injection, offering a cost-effective solution for diabetes and weight...

Generic Semaglutide: Indian Firms Challenge Novo Nordisk A modern pharmaceutical manufacturing facility with robotic arms and human workers in clean suits overseeing the production of generic semaglutide vials and pens.

A modern pharmaceutical manufacturing facility with robotic arms and human workers in clean suits overseeing the production of generic semaglutide vials and pens.

Generic Semaglutide: Indian Firms Challenge Novo Nordisk

sivam March 21, 2026

Indian firms launch generic semaglutide, challenging Novo Nordisk's Ozempic & Wegovy. Affordable access to diabetes & weight...

Dr. Reddy’s Launches Semaglutide ‘Obeda’ in India Semaglutide injectables and vials on a lab bench with scientists and manufacturing equipment in the background.

Semaglutide injectables and vials on a lab bench with scientists and manufacturing equipment in the background.

Dr. Reddy’s Launches Semaglutide ‘Obeda’ in India

sivam March 21, 2026

Dr. Reddy's Laboratories introduces Obeda, a semaglutide injectable, in India, enhancing their diabetes care portfolio. A new...

Dr. Reddy’s Launches Semaglutide ‘Obeda’ for Diabetes Medical professional with Obeda medication, syringe, and DNA helix in a sterile pharmaceutical manufacturing lab.